approve of

(redirected from approve)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.

approve of

To agree with or support someone or something. I don't approve of your behavior right now. My parents have never approved of any of my girlfriends.
See also: of

approve of someone or something

to take a favorable view of someone or something. I approve of the way you have remodeled the kitchen. I don't approve of your foul language.
See also: of

approve of

v.
To consider someone or something right, good, or appropriate: My voice teacher does not approve of eating ice cream before singing. My parents need to know exactly where I plan to go before they can approve of my trip.
See also: of
References in periodicals archive ?
The FDA approves new formulation of saquinavir (Fortovase, a soft-gel formulation designed to improve absorption in the body).
The FDA approves Combivir, a combination of zidovudine (Retrovir, AZT) and lamivudine (Epivir, 3TC).
The FDA approves a supplement to the Amplicor HIV-1 Monitor Test, extending the lower limit of viral load quantification from 400 to 50 copies/mL.
The FDA approves Kaletra, a combination pill containing 2 PIs, lopinavir and ritonavir (Norvir), where a small dose of ritonavir is included to boost levels of lopinavir.
The FDA approves Glaxo Wellcome's application to market Trizivir.
The FDA approves a film-coated nelfinavir (Viracept) tablet (for ease of administration).
The FDA approves Bristol-Myers Squibb's enteric-coated didanosine (Videx EC) capsules.
The FDA approves the first genetic test designed to look at virus mutations in an HIV-infected person.
The FDA approves Zerit XR, a new once-daily version of Zerit (stavudine), which never comes to market.
The FDA approves OraQuick Rapid HIV-1 Antibody Test, the first rapid test to use a finger prick.
The FDA approves a new 600-mg version of efavirenz (Sustiva) to reduce pill burden.
The FDA approves the first entry inhibitor enfuvirtide Fuzeon, T20).
The FDA approves Truvada, a fixed-dose, once-daily, co-formulation of the NRTIs emtricitabine (Emtriva, FTC) and tenofovir (Viread).